Celecoxib vs Ipilimumab

Celecoxib vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Celecoxib and Ipilimumab.

Mechanism of Action

Celecoxib: Selective COX-2 inhibitor.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Celecoxib — 11 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Celecoxib — C17H14F3N3O2S.

Molecular Weight: Celecoxib — 381.3730 g/mol.

Type: Celecoxib — Small molecule; Ipilimumab — Antibody.